Abuse
- Sexual predators prove elusive - WHW Dec 2006
- Women talk about childhood sexual abuse - WHU Oct 2004
- Rohypnol tablets not available in NZ - WHW Sept 1999
See Sexual Abuse in doctor- patient relationship for the following articles:
- Sexual predators prove elusive - WHW Dec 2006
- Medical Council Guidelines for patient/doctor relationships - WHU Jan 07
- Submission on Draft Paper: Boundaries for the doctor-patient relationship - January 2004
- Sexual boundaries update - WHW Sept 2002
- Sexual misconduct update - WHW March 2002
- Update on sexual boundaries in the doctor/patient relationship - WHW Dec 2001
- Sexual boundaries and doctors - WHW Jun 2001
- Dealing with sexual abuse by doctors - WHW Dec 2000
- All fired up over Fahey - WHW Sept 2000
See also: Violence
Sexual predators prove elusive
December 2006 Women's Health Watch
The Medical Council explained that the difference between their investigation and the Court Proceedings was in the weight of evidence twelve women and a substantial body of complaint. They qualified their comments by saying there was little evidence remaining on the initial investigations but what there was suggested that "it came down to the problem of one person's opinion against another." It is clear whose opinion they believed and worrying those two separate complaints failed to alert them to any danger to women patients....Read More
Women talk about childhood sexual abuse
October 2004 Women's Health Update
Women's Health Action was delighted to have Dr Kim McGregor as the guest speaker at our 16th anniversary lunch celebration of the release of the Cartwright Report. Kim's presentation on her groundbreaking research was engaging and informative. At our request Dr McGregor has provided the following summary of her yet to be published research. It provided her "with an opportunity to 'give back' some of the findings" from her research with Aotearoa/New Zealand women who had experienced childhood sexual abuse (CSA). Read More (pdf)
Rohypnol tablets not available in NZ
September 1999 Women's Health Watch
According to the Ministry of Health's senior medical advisor, Stewart Jessamine, Rohypnol tablets were withdrawn by the sponsor, Roche (NZ) Ltd, from the New Zealand market several years ago due to falling market share and increasing Ministry concerns about abuse. Police reports indicate that in Europe and the United States the drinks of rape victims had been spiked with Rohypnol preceding the attack. Although there is no evidence to suggest Rohypnol had been used in date rape cases in New Zealand, Dr Jessamine says it was regularly abused by New Zealand drug users during the late 1980's. 3:
The intravenous formulation of Rohypnol is now only available to specialists in palliative care if requested.
Previous page: Abortion
Next page: Advertising